Trial NCT02856568

View at ClinicalTrials.gov 
Org. Study IDs: MC1542
Secondary IDs: MC1542 NCI-2016-01057 P30CA015083

Last trial update was posted on 2017-05-30

MeSH Interventions

Cisplatin Gemcitabine Ricolinostat

MeSH Conditions

Bile Duct Neoplasms Carcinoma, Ductal Cholangiocarcinoma Klatskin Tumor

Other Conditions

Non-Resectable Cholangiocarcinoma Recurrent Cholangiocarcinoma Stage III Extrahepatic Bile Duct Cancer Stage III Intrahepatic Cholangiocarcinoma Stage IIIA Hilar Cholangiocarcinoma Stage IIIB Hilar Cholangiocarcinoma Stage IVA Extrahepatic Bile Duct Cancer Stage IVA Hilar Cholangiocarcinoma Stage IVA Intrahepatic Cholangiocarcinoma Stage IVB Extrahepatic Bile Duct Cancer Stage IVB Hilar Cholangiocarcinoma Stage IVB Intrahepatic Cholangiocarcinoma Unresectable Extrahepatic Bile Duct Carcinoma

Stopping Reasons

Site dropped study

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID